₹336.40▼ −9.15 · −2.6%from ₹345.55 the session before · 1 Oct 2026 close · NSE end of day
Open
₹342.80
High
₹346.45
Low
₹327.95
Day's range
₹195.4% of the previous close
VWAP
₹335.48close +0.27% from it
Volume, shares
8.0 L0.55× the 20-session average
Turnover, ₹ crore
27
Trades
33,00024 shares per trade
Previous close
₹345.55−9.15 to the close
Price band, next session
₹302.75 – ₹370.0510% either side of the close · dynamic, widened in 5% steps when hit
Day range46% of the way up
₹327.95₹346.45
52-week range76% of the way up
₹203.35 30 Mar₹378.80 25 Sept
−11% from the high · +65% from the low
Futures and options
No derivatives listed on ARTEMISMED
Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it
Revenue ₹287 cr; profit ₹31 cr in the Jun 2026 quarter, consolidated.
Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of ARTEMISMED on the consolidated basis with the market's move on the first session after each filing
Quarter
Revenue ₹ cr
Revenue YoY
Profit ₹ cr
Profit YoY
EPS ₹
Market on the day
Jun 2026filed 3 Aug
₹287 cr
—
₹31 cr
—
1.98
▼ −0.1%Nifty −0.6% · +0.5 pp
Mar 2026filed 8 May · audited
₹279 cr
—
₹30 cr
—
1.90
▲ +5.8%Nifty −1.5% · +7.3 pp
Fundamentals
consolidated · filings to Jun 2026 · close ₹336.40 on 1 Oct
5.7 times book value, a 0.27% dividend yield, market cap ₹5,300 cr.
Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
₹5,300 cron 1 Oct · free float ₹2,200 cr
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
5.7consolidated · balance sheet to Mar 2026
Book value a share
₹59.42consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity
0.24borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity
—needs two filed balance sheets
Dividend yield
0.27%₹0.90 a share in 365 days
Face value
₹1a share
Shares outstanding
16 cron 1 Oct
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed
PeersBSE sub-group Hospital · F&O stocks with filings on record · industry P/E 58, market caps over trailing profit of 4 stocks
Stocks in the BSE sub-group Hospital with market cap, price to earnings and price to book
Promoters hold 58.4%, foreign portfolio investors 12.3%, mutual funds 1.3% and banks and financial institutions 1.1%, as filed for the quarter to 30 Jun.
58.4%12.3%13.4%13.5%
Promoters 58.4%
Foreign portfolio investors 12.3%
Mutual funds 1.3%
Banks and financial institutions 1.1%
Individual investors 13.4%
Others 13.5%
By category, last 2 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of ARTEMISMED by category over the last 2 quarters with the change against the previous quarter
Category
30 Jun
31 Mar
Promoters
58.390.00 pp
58.39
Foreign portfolio investors
12.28▲ +0.09 pp
12.19
Mutual funds
1.30▼ −0.39 pp
1.69
Banks and financial institutions
1.10▼ −0.10 pp
1.20
Individual investors
13.40▲ +0.45 pp
12.95
Bodies corporate
2.18▼ −0.09 pp
2.27
Government
6.160.00 pp
6.16
Others
5.19▲ +0.04 pp
5.15
Corporate actions
NSE and BSE records
Nothing upcoming on record; the last was a dividend of ₹0.45 a share, ex-date 10 Jul 2026.
Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios
Corporate actions of ARTEMISMED, upcoming first, then the most recent
Ex-date
Action
Amount or ratio
Record date
Source
recent
10 Jul 2026
dividend
₹0.45
10 Jul 2026
BSE
11 Jul 2025
dividend
₹0.45
11 Jul 2025
BSE
5 Jul 2024
dividend
₹0.45
5 Jul 2024
BSE
Calendaras notified to the exchange
Next results
—no board meeting notified yet
Dividends in 365 days
₹0.90a share · ex-dates inside the year
Last dividend
₹0.45ex-date 10 Jul 2026
Price history
272 sessions on record · to 1 Oct · NSE end of day
ARTEMISMED is +4.9% over 20 sessions against Nifty's −6.2%, 11% below its 52-week high, realised volatility 49% annualised.
Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
Window
From ₹
ARTEMISMED %
Nifty 50 %
Difference pp
250 sessionssince 26 Sept
₹232.02
▲ +45%
▼ −9.1%
+54
120 sessionssince 9 Apr
₹227.71
▲ +48%
▼ −5.7%
+53
60 sessionssince 8 Jul
₹263.49
▲ +28%
▼ −6.1%
+34
20 sessionssince 2 Sept
₹320.69
▲ +4.9%
▼ −6.2%
+11
5 sessionssince 24 Sept
₹332.71
▲ +1.1%
▼ −2.8%
+3.9
1 sessionsince 30 Sept
₹345.56
▼ −2.6%
▼ −0.88%
−1.8
Averages of the closeclose against each average
5-session average
₹354.43close −5.1% from it
20-session average
₹341.89close −1.6% from it
50-session average
₹322.78close +4.2% from it
200-session average
₹269.70close +25% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹185.3% of the close
Average day's range, 20
₹164.7% of the close
Volume against 20 sessions
0.55×8.0 L vs 15 L average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
49%≈ ±3.1% a session · moved more than that on 6 of 20
Realised volatility, 60
39%≈ ±2.5% a session · moved more than that on 13 of 60
Realised volatility, 250
37%≈ ±2.3% a session · moved more than that on 59 of 250
Beta to Nifty, 60
1.42moved with Nifty on 39 of 60 sessions
Beta to Nifty, 250
0.84moved with Nifty on 153 of 250 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
11 up · 9 downof 20
Last 60 sessions
32 up · 28 downof 60
Last 250 sessions
134 up · 116 downof 250
Best session, 250
▲ +8.3%1 Apr
Worst session, 250
▼ −9.2%3 Feb
0 bulletins on ARTEMISMED
The desk has not written about Artemis Medicare Services Limited yet. The tape carries every bulletin as it is published.
About Artemis Medicare Services Limited
exchange masters as of 18 Sept 2026 · classification by BSE
Company
Artemis Medicare Services Limited
Exchange
NSE · BSE 542919, group B
Listed on NSE
23 Jan 2020
Classification
Healthcare › Healthcare Services › Hospital
Index
BSE 1000
Face value
₹1 a share
ISIN
INE025R01021
Sessions on record
272
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
2 Oct, 12:06 am IST
Bulletins
0 · written by the desk · not a recommendation
OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.